key: cord-0015940-usffxq12
authors: Liu, Fang; Liu, TianTian; Sun, Min; Zhou, JingMin; Xue, Feng; Chen, ShuangHui; Chen, Jia; Zhang, Lei
title: Maxing Shigan Decoction Mitigates Mycoplasma pneumonia-Induced Pyroptosis in A549 Cells via the NLRP3 Inflammasome
date: 2021-03-03
journal: Infect Drug Resist
DOI: 10.2147/idr.s292413
sha: 70b131a415307b3fdfed87469e0ac01720fe69a2
doc_id: 15940
cord_uid: usffxq12

BACKGROUND: Mycoplasma pneumoniae is a predominant cause of community-acquired respiratory infections. We recently discovered the clinical efficacy of Maxing shigan decoction (MXSG) in M. pneumoniae infection and designed a study to explore the mechanism of action. METHODS: Serum IL-1β, IL-18, and TNF-α, and transcript expression of the NLR Family, Pyrin Domain Containing Protein 3 (NLRP3) were measured in the peripheral blood mononuclear cells (PBMCs) of 30 children with M. pneumoniae infection and 30 healthy donors. An in vitro model of M. pneumoniae infection in A549 cell culture was used to explore the curative effects and mechanisms of MXSG. Pyroptosis was measured by flow cytometry with activated caspase-1 and propidium iodide staining. IL-1β, IL-18, and TNF-α, and NLRP3 transcript expression were measured by qRT-PCR. Protein expression of NLRP3, Caspase-1, pro-caspase-1, IL-1β, pro-IL-1β, and GSDMD-N was determined by Western blotting. Experimental confirmation was performed in NLRP3-overexpressing A549 cells and in the presence of an NLRP3 inhibitor, INF39. RESULTS: M. pneumoniae infection-induced IL-1β, IL-18, TNF-α, and mRNA expression of NLRP3 in PBMCs and promoted pyroptosis in A549 cells. It also induced IL-1β, IL-18, TNF-α, and up-regulated NLRP3, ro-IL-1β, Caspase-1, Pro-Caspase-1, and GSDMD-N in culture. Similar to the NLRP3 inhibitor INF39, MXSG (0.1, 0.2, and 0.4 mg/mL) suppressed pyroptosis induced by M. pneumoniae infection and decreased IL-1β (P < 0.001), IL-18, TNF-α in culture. MXSG down-regulated NLRP3, pro-IL-1β, Caspase-1, pro-Caspase-1, and GSDMD-N in infected cultures and mitigated NLRP3 overexpression-induced pyroptosis. CONCLUSION: MXSG mitigates M. pneumoniae-induced pyroptosis in A549 cells via the NLRP3 inflammasome.

Mycoplasma pneumoniae is one of the smallest self-replicating microorganisms. A harmful human pathogen, M. pneumoniae is one of the primary causes of community-acquired respiratory infections, leading to life-threatening tracheobronchitis and pneumonia. 1, 2 Although the diagnosis of M. pneumoniae has dramatically improved, the available treatments (macrolides antibiotics, quinolones, and glucocorticoids) are not fully effective against this pathogen in the respiratory tract. [2] [3] [4] [5] Alternative remedies for M. pneumoniae respiratory infections are urgently needed. In recent years, numerous pharmacological studies have shown that traditional Chinese medicine (TCM) can effectively treat several intractable diseases, particularly inflammatory diseases and infections caused by drug-resistant bacteria. 6, 7 Viral and bacterial infections result in an inflammasomemediated immune response. The inflammasome induces the release of pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-18, leading to Caspase-1 activation and pyroptosis. 8, 9 Maxing shigan decoction (MXSG) is a classic TCM formula composed of whole Ephedra sinica herb, Prunus armeniaca seeds, Glycyrrhiza uralensis roots, and gypsum. MXSG is commonly used to treat respiratory tract diseases, including upper respiratory tract infection, acute bronchitis, pneumonia, chronic obstructive pulmonary disease, and bronchial asthma. [10] [11] [12] The active components of MXSG are ephedrine, pseudoephedrine, methylephedrine, amygdalin, amygdalin prunasin, glycyrrhizic acid, liquiritin, glycyrrhizin, and CaSO 4 . 10, 13, 14 MXSG is also an effective therapy for M. pneumoniae infection, 15, 16 although its mechanism of action is unknown. This study aimed to explore the mechanism of MXSG action in M. pneumoniae infection to support further pharmaceutical development of Maxing shigan decoction. A549 cell cultures have been used to explore the effects of M. pneumonia infection on IL-8 release and pyroptosis in human lung epithelial cells, so the same cell line was used in the current study.

Ethical approval for the study was provided by the independent Ethics Committee of Pudong New Area People's Hospital. Written informed consent was obtained from the guardians of all participants prior to enrollment. This study was conducted in accordance with the Declaration of Helsinki.

We enrolled 30 children (mean age 31 months, 17 male, 13 female) with M. pneumoniae infection admitted to the Department of Pediatrics, Pudong New Area People's Hospital (Shanghai, China). Nasopharyngeal aspirate samples were collected for M. pneumonia detection. Patients were excluded if they had chronic lung disease, immunodeficiency, congenital heart disease, or bronchopulmonary dysplasia. Fasting blood samples were obtained before treatment. Fasting blood samples were collected from 30 age-matched healthy donors as controls. Serum samples were obtained by centrifugation and stored at-80°C. Peripheral blood mononuclear cells (PBMCs) were isolated by centrifugation at 300 × g for 30 min with lymphocyte isolation reagent.

Total RNA was extracted using Trizol reagent according to the manufacturer's protocol (Invitrogen Life Technologies), and 1 μg of each sample was reverse transcribed using the Revert Aid TM First Strand cDNA Synthesis Kit (#K1622; Thermo) with random primers. NLRP3 transcript expression was measured by qRT-PCR with SYBR Green PCR Master Mix (#K0223; Thermo) according to manufacturer instructions with GAPDH as an internal control on an ABI 7300 thermocycler (Applied Biosystems, Foster City, CA, USA). The 2 −ΔΔCt relative quantification method was applied. Primer sequences were NLRP3 (5′-AGCCTCAACAAACGCTACAC-3′ and 5′-CATCATCGGGGTCAAACAG-3′), GAPDH (5′-AATCC CATCACCATCTTC-3′ and 5′-AGGCTGTTGTCATAC TTC-3′).

Measurement of IL-1β, IL-18, and TNF-α Serum and supernatant IL-1β, IL-18, and TNF-α content was measured by enzyme-linked immunosorbent assay (ELISA; Jiancheng, Nanjing, China).

M. pneumoniae strain 29,342 (American Type Culture Collection, Rockville, MD) was grown in broth containing mycoplasma broth base CM403 and selective supplement G SR59 (Oxoid, Hampshire, UK), 0.5% glucose, and 0.002% phenol red at 37°C in the presence of 5% CO 2 for 3 days. Viable M. pneumoniae was quantified by colony counting in 10-fold serial dilutions on mycoplasma agar. Infection was induced by adding 1 mL M. pneumoniae to 10 mL cell medium (approximately 1 × 10 7 CFU/10 6 A549 cells) unless otherwise specified and incubated for 12 h, 24 h, or 48 h. Negative controls were A549 cell cultures with 1 mL bacteria-free mycoplasma broth.

The herbal medicines (whole Ephedra sinica, Prunus armeniaca seeds, Glycyrrhiza uralensis roots, and gypsum) were powdered and soaked in purified water for 30 min for 1.5 h. The extracts were, then decocted filtered and concentrated at 50°C using a rotary vacuum evaporator. The water extracts were then freeze-dried.

The full-length human NLRP3 was cloned into pLVXpuro (Clontech, Palo Alto, CA, USA), then pLVX-NLRP3 (oeNLRP3) and pLVX-puro (vector control) were propagated in 293T cells along with packaging plasmids psPAX2 and pMD2.G.

The treated cells were collected and resuspended in staining buffer, then incubated with FLICA 660-YVAD-FMK (FLICA 660 Caspase-1 Assay, Catalog number: 9122) and propidium iodide (PI, Thermo Fisher) for 25 min at 4°C. The ratios of activates caspase-1 and PIpositive cells were analyzed by flow cytometry (BD Biosciences).

A549 cells were lysed in ice-cold RIPA lysis buffer (Beyotime Biotechnology), and total protein was quantified by BCA protein assay (Thermo Fisher) according to standard protocols. Protein extracts (25 μg) were resolved by 10% or 12% SDS polyacrylamide gel 

Each experiment was conducted at least three times. Statistical analysis between more than two groups and between two groups was performed using ANOVA and Student's t-test, respectively. A P-value <0.05 was considered significant. Data are presented as means ± standard deviations. 

Serum levels of IL-1, IL-18, and TNF-α, and mRNA expression of NLRP3 in PBMCs were significantly higher in patients than in healthy controls (Figure 1 , P < 0.01). 

We then explored whether NLRP3 mediated the antipyroptosis effects of MXSG in A549 cells. A549 cells overexpressing NLRP3 were exposed to M. pneumonia and 0.2 mg/mL MXSG. The results showed that NLRP3 overexpression significantly suppressed the inhibitory effects of MXSG on NLRP3 expression, pyroptosis, pro-inflammatory cytokines IL-18, TNF-α, and IL-1β, as well as pro-IL-1β, Caspase-1, pro-Caspase-1, and GSDMD-N ( Figure 4 ).

NLRP3 overexpressing A549 cells were used to determine the anti-pyroptotic effects of MXSG ( Figure 5A ). NLRP3 overexpression-induced significant pyroptosis in A549 cells compared to the vector group (P < 0.01); however, MXSG counteracted this effect ( Figure 5B ). Our results also indicated that MXSG (P < 0.05) suppressed the induction of pro-inflammatory cytokines such as IL-18, TNF-α, and IL-1β induced by NLRP3 overexpression (Figure 5C-F) . MXSG also down-regulated NLRP3 ( Figure 5A ), pro-IL-1β, Caspase-1, pro-Caspase-1 ( Figure 5F ), and GSDMD-N ( Figure 5G ) in NLRP3overexpressing A549 (P < 0.05).

M. pneumoniae is one of the most common causes of community-acquired pneumonia and is closely related to the development of asthma. It is widely believed that an outbreak of M. pneumoniae would bring about a public health emergency. 1, 17 We explored the curative effect and Pyroptosis, closely related to the inflammatory response, is a recently identified pathway of programmed cell death. [18] [19] [20] Unlike apoptosis, which is physiological suicide, pyroptosis is pathological suicide commonly caused by a viral or bacterial infection. Pyroptosis results in rupture of the cellular membrane and leakage of cytoplasm, triggering an inflammatory response. 21, 22 Pyroptosis induces pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-18, exacerbating the inflammatory response. 23, 24 NLRP3 has been associated with the development of pyroptosis. 25, 26 Here, we found increased serum levels of IL-1β, IL-18, TNF-α, and mRNA expression of NLRP3 in PBMCs of children with M. pneumoniae infection compared to healthy children. In the future, we will determine whether pyroptosis occurs in PBMCs of children with M. pneumonia infection. We found that M. pneumoniae infection induces time-dependent pyroptosis in A549 lung cancer cells as well as serum IL-1β, TNF-α, and IL-18, and NLRP3 expression. The NLRP3 inflammasome is an important member of the NLR family and comprises NLRP3, ASC, and pro-caspase 1. 27 Pyroptosis is mediated by activation of the NLRP3 inflammasome and Caspase-1, as well as Gasdermin D (GSDMD-N). [28] [29] [30] Importantly, our results suggest that M. pneumoniae infection causes timedependent upregulation of NLRP3, Caspase-1, pro-caspase-1, and GSDMD-N in A549 cells. We thus speculated that M. pneumoniae induces pyroptosis in these cultures via regulation of the NLRP3 inflammasome. Thus, we determined the effects of the NLRP3 inhibitor INF39 on M. pneumoniae infection-induced pyroptosis in A549 cells. Indeed, INF39 abrogated infection-induced pyroptosis and NLRP3 overexpression induced pyroptosis in A549 cells.

TCM provides a broad spectrum of therapies derived from natural active compounds that mitigate disease. 31, 32 Indeed, we found that the effects of Maxing shigan decoction on M. pneumoniae infectioninduced pyroptosis were similar to that of INF39, inhibiting the production of pro-inflammatory cytokines. This effect was abrogated by NLRP3 overexpression. MXSG treatment also down-regulated the expression of NLRP3, Pro-IL-1β, Caspase-1, pro-caspase-1, and GSDMD-N in M. pneumoniae-infected and NLRP3overexpressing A549 cells.

In conclusion, our findings suggest Maxing shigan decoction mitigates M. pneumoniae-induced pyroptosis in A549 cells via the NLRP3 inflammasome, supporting the further pharmaceutical development of Maxing shigan decoction.

This work was supported by the Important Weak Subject Construction Project of Pudong Health and Family Planning Commission of Shanghai (Grant No. PWZbr2017-23).

Mycoplasma pneumoniae from the respiratory tract and beyond

Insights into the pathogenesis of Mycoplasma pneumoniae (review)

Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children

Macrolide-resistant Mycoplasma pneumoniae infection

Research progress of macrolide-resistant Mycoplasma pneumonia

Nose to brain drug deliverya promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion

Traditional Chinese medicine for COVID-19 treatment

Activation of inflammasomes in dendritic cells and macrophages by Mycoplasma salivarium

Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells

Influence of compatibility on content of berberine in Maxingganshi decoction

Effect of maxingganshi decoction on the expression of STAT4 and STAT6 in lung tissues of rats with chronic obstructive pulmonary disease

Study on active compounds from Maxingganshi decoction for treatment of novel coronavirus pneumonia (COVID-19) based on network pharmacology and molecular docking method

Dose-response relationship of main components of Ma Xing Shi Gan decoction with relaxing tracheal smooth muscle

UPLC fingerprint chromatography of Maxingshigan decoction

Treating refractory Mycoplasma pneumonia pneumonia with Maxin Shigan decoction

Clinical observation and analysis of Maxing Shigan decoction combined with Azithromycin in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Chin Arch Tradit Chin Med

Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections

The role of pyroptosis in cancer: procancer or pro-"host

Pyroptosis versus necroptosis: similarities, differences, and crosstalk

Pyroptosis, a novel form of programmed cellular necrosis

Influenza A virus infection triggers pyroptosis and apoptosis of respiratory epithelial cells through the Type I interferon signaling pathway in a mutually exclusive manner

Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages

Study on protective mechanism of resveratrol against pyroptosis induced by lipopolysaccharide in human lung epithelial cells

Related research progress of NLRP3 inflammatory corpuscle and pyroptosis

NLRP3 inflammasome induces pyroptosis in lung tissues of radiation-induced lung injury in mice

NLRP3 is a critical regulator of inflammation and innate immune cell response during Mycoplasma pneumoniae infection

Pharmacological inhibitors of the NLRP3 inflammasome

Caspase-1-induced pyroptotic cell death

Pyroptosis: gasdermin-mediated programmed necrotic cell death

NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/ reperfusion injury in diabetic rats

A network pharmacology approach to investigate the anticancer mechanism and potential active ingredients of Rheum palmatum L. against lung cancer via induction of apoptosis

Data mining and systematic pharmacology to reveal the mechanisms of traditional Chinese medicine in Mycoplasma pneumoniae pneumonia treatment

The authors declare that they have no competing interests.

Infection and Drug Resistance is an international, peer-reviewed openaccess journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance. The journal is specifically concerned with the epidemiology of antibiotic resistance and the mechanisms of resistance development and diffusion in both hospitals and the community. The manuscript management system is completely online and includes a very quick and fair peerreview system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.